Novartis Shareholders Approve Dividend Raise, Share Capital Reduction

MT Newswires Live

Mar 06

Novartis (NVS) said Friday its shareholders have approved a dividend increase of 5.7% to 3.70 Swiss francs ($4.74) per share for 2025.

The dividend will be paid from March 12, Novartis said.

Shareholders have also approved a proposal by the board to cancel about 77.6 million shares and to decrease the share capital accordingly by about 38 million Swiss francs to roughly 997.1 million Swiss francs, the company said.

Shareholders also confirmed Giovanni Caforio as board chair, as well as the other members of the board who stood for re-election, the company said. Charles Swanton was newly elected as member of the board, Novartis said, adding Daniel Hochstrasser did not stand for re-election.

Price: 158.30, Change: -2.71, Percent Change: -1.68

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2617777636"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2617777636\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2617777636?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 23:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2617777636","market":"fut","top_or_hot":-1,"title":"Novartis Shareholders Approve Dividend Raise, Share Capital Reduction","media":"MT Newswires Live","content":"<html><body><p> Novartis (NVS) said Friday its shareholders have approved a dividend increase of 5.7% to 3.70 Swiss francs ($4.74) per share for 2025.</p><p>The dividend will be paid from March 12, Novartis said.</p><p>Shareholders have also approved a proposal by the board to cancel about 77.6 million shares and to decrease the share capital accordingly by about 38 million Swiss francs to roughly 997.1 million Swiss francs, the company said.</p><p>Shareholders also confirmed Giovanni Caforio as board chair, as well as the other members of the board who stood for re-election, the company said. Charles Swanton was newly elected as member of the board, Novartis said, adding Daniel Hochstrasser did not stand for re-election.</p><p>Price: 158.30, Change: -2.71, Percent Change: -1.68</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novartis Shareholders Approve Dividend Raise, Share Capital Reduction</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovartis Shareholders Approve Dividend Raise, Share Capital Reduction\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-06 23:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Novartis (NVS) said Friday its shareholders have approved a dividend increase of 5.7% to 3.70 Swiss francs ($4.74) per share for 2025.</p><p>The dividend will be paid from March 12, Novartis said.</p><p>Shareholders have also approved a proposal by the board to cancel about 77.6 million shares and to decrease the share capital accordingly by about 38 million Swiss francs to roughly 997.1 million Swiss francs, the company said.</p><p>Shareholders also confirmed Giovanni Caforio as board chair, as well as the other members of the board who stood for re-election, the company said. Charles Swanton was newly elected as member of the board, Novartis said, adding Daniel Hochstrasser did not stand for re-election.</p><p>Price: 158.30, Change: -2.71, Percent Change: -1.68</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2617777636","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2617777636","pubTimestamp":1772809658,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Novartis  said Friday its shareholders have approved a dividend increase of 5.7% to 3.70 Swiss francs  per share for 2025.The dividend will be paid from March 12, Novartis said.Shareholders have also approved a proposal by the board to cancel about 77.6 million shares and to decrease the share capital accordingly by about 38 million Swiss francs to roughly 997.1 million Swiss francs, the company said.Shareholders also confirmed Giovanni Caforio as board chair, as well as the other members of the board who stood for re-election, the company said. Charles Swanton was newly elected as member of the board, Novartis said, adding Daniel Hochstrasser did not stand for re-election.Price: 158.30, Change: -2.71, Percent Change: -1.68","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","NVS":"诺华","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","BK4588":"碎股","BK4578":"CAR-T","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","BK4585":"ETF&股票定投概念","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","BK4532":"文艺复兴科技持仓","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC"},"translate_title":"诺华股东批准提高股息、削减股本","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVS":1},"content_text":"Novartis (NVS) said Friday its shareholders have approved a dividend increase of 5.7% to 3.70 Swiss francs ($4.74) per share for 2025.The dividend will be paid from March 12, Novartis said.Shareholders have also approved a proposal by the board to cancel about 77.6 million shares and to decrease the share capital accordingly by about 38 million Swiss francs to roughly 997.1 million Swiss francs, the company said.Shareholders also confirmed Giovanni Caforio as board chair, as well as the other members of the board who stood for re-election, the company said. Charles Swanton was newly elected as member of the board, Novartis said, adding Daniel Hochstrasser did not stand for re-election.Price: 158.30, Change: -2.71, Percent Change: -1.68","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}